Auditory and vestibular manifestations of Vogt-Koyanagi-Harada disease

被引:14
作者
Al Dousary, S. [1 ]
机构
[1] King Saud Univ, King Abdul Aziz Univ Hosp, Coll Med, Dept Otorhinolaryngol, Riyadh 11411, Saudi Arabia
关键词
Vogt-Koyanagi-Harada Disease; Hearing Loss; Vertigo; Uveitis; Vitiligo; Melanocytes; Corticosteroids; Cochlear Implant; REVISED DIAGNOSTIC-CRITERIA; CORTICOSTEROIDS; CYCLOSPORIN; THERAPY;
D O I
10.1017/S0022215110001817
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Introduction and aims: Vogt-Koyanagi-Harada disease is a chronic disorder involving the eye and the central nervous, auditory, vestibular and integumentary systems. This study aimed to determine the auditory and vestibular manifestations of this disease. Methods: Twenty-four patients diagnosed with Vogt-Koyanagi-Harada disease were assessed for auditory and vestibular dysfunction. Results: Uveitis presents in all cases. Sensory hearing loss was present in 50 per cent of cases, tinnitus in 42 per cent, vertigo in 17 per cent and headache in 17 per cent. Nine patients received systemic steroids. Six patients who were treated early regained their hearing, but three patients whose treatment was delayed did not. One patient with bilateral profound hearing loss underwent cochlear implantation, and achieved excellent post-implantation hearing. Conclusion: There is a high incidence of cochlear and vestibular end-organ involvement in patients with Vogt-Koyanagi-Harada disease. The adequacy and timing of treatment has a significant effect on the disease outcome. Vogt-Koyanagi-Harada disease appears to affect the inner ear end-organ. Patients who develop bilateral profound sensory hearing loss are suitable candidates for cochlear implantation.
引用
收藏
页码:138 / 141
页数:4
相关论文
共 18 条
[1]   ECHOGRAPHIC FEATURES OF THE VOGT-KOYANAGI-HARADA SYNDROME [J].
FORSTER, DJ ;
CANO, MR ;
GREEN, RL ;
RAO, NA .
ARCHIVES OF OPHTHALMOLOGY, 1990, 108 (10) :1421-1426
[2]  
HAYASAKA S, 1982, GRAEF ARCH CLIN EXP, V218, P9, DOI 10.1007/BF02134092
[3]   MAGNETIC-RESONANCE-IMAGING FINDINGS IN VOGT-KOYANAGI-HARADA SYNDROME [J].
IBANEZ, HE ;
GRAND, MG ;
MEREDITH, TA ;
WIPPOLD, FJ .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 1994, 14 (02) :164-168
[4]  
KAHN M, 1993, OPHTHALMOLOGY, V100, P1191
[5]   Clinical study of the role of melanocytes in the inner ear of patients with Harada's disease [J].
Kimura, H ;
Ohashi, N ;
Aso, S ;
Watanabe, Y .
ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES, 1996, 58 (04) :233-237
[6]  
MAXWELL ON, 1963, ARCHIV OTOLARYNGOL, V78, P138
[7]   CYCLOSPORIN A THERAPY IN THE TREATMENT OF INTRAOCULAR INFLAMMATORY DISEASE RESISTANT TO SYSTEMIC CORTICOSTEROIDS AND CYTO-TOXIC AGENTS [J].
NUSSENBLATT, RB ;
PALESTINE, AG ;
CHAN, CC .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1983, 96 (03) :275-282
[8]  
PANITRUNGROUNG T, 1999, THAI J DERMATOL, V15, P208
[9]   Evaluation of the effect on outcomes of the route of administration of corticosteroids in Acute Vogt-Koyanagi-Harada disease. [J].
Read, Russell W. ;
Fei Yu ;
Accorinti, Massimo ;
Bodaghi, Bahram ;
Chee, Soon-Phaik ;
Fardeau, Christine ;
Goto, Hiroshi ;
Holland, Gary N. ;
Kawashima, Hidetoshi ;
Kojima, Eri ;
Lehoang, Phuc ;
Lemaitre, Claire ;
Okada, Annabelle A. ;
Pivetti-Pezzi, Paola ;
Secchi, Antonio ;
See, Robert F. ;
Tabbara, Khalid F. ;
Usui, Masahiko ;
Rao, Narsing A. .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2006, 142 (01) :119-124
[10]   Utility of existing Vogt-Koyanagi-Harada syndrome diagnostic criteria at initial evaluation of the individual patient: a retrospective analysis [J].
Read, RW ;
Rao, NA .
OCULAR IMMUNOLOGY AND INFLAMMATION, 2000, 8 (04) :227-234